Grants per year
Personal profile
Research Interests
Neuromuscular Disorders: Amyotrophic Lateral Sclerosis Muscular Dystropy Peripheral Neuropathy
Certifications and Licenses
| Neuromuscular Medicine | |
| Neurology |
Training Experience
| 2004 | Residency, Univ. of Illinois Hospital |
| 2005 | Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
Education/Academic qualification
MD, University of Tunis
… → 1996
Keywords
- ALS
- Amyotrophic Lateral Sclerosis
- Muscular Dystrophy
- Nervous System Diseases
- Neuromuscular Disorders
- Peripheral Neuropathy
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 3 Similar Profiles
Amyotrophic Lateral Sclerosis
Medicine & Life Sciences
Diabetes Complications
Medicine & Life Sciences
Type 1 Diabetes Mellitus
Medicine & Life Sciences
Mutation
Medicine & Life Sciences
Epidemiology
Medicine & Life Sciences
Motor Neurons
Medicine & Life Sciences
Charcot-Marie-Tooth Disease
Medicine & Life Sciences
Motor Neuron Disease
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 1999 2021
ODM-109:Effects of Oral Levosimendan(ODM-109) on Respiratory Function in Patients with ALS:
PRA Health Sciences, Orion Group
5/31/18 → 5/31/21
Project: Research project
Consortium Member and Peripheral Neuropathy Research Registry Agreement
Foundation for Peripheral Neuropathy
1/1/18 → 12/31/18
Project: Research project
Peripheral Nervous System Diseases
Registries
Research
Neuralgia
Neurologic Examination
Answer ALS: Individualized Initiative for ALS Discovery
Johns Hopkins University, Les Turner Amyotrophic Lateral Sclerosis Foundation, Ltd.
1/1/18 → 12/31/19
Project: Research project
Amyotrophic Lateral Sclerosis
Biomarkers
Research Personnel
Pharmaceutical Preparations
Research
Research Output 1998 2018
Intravenous versus subcutaneous immunoglobulin – Authors' reply
PATH study group, May 1 2018, In : The Lancet Neurology. 17, 5, p. 393-394 2 p.Research output: Contribution to journal › Letter
Immunoglobulins
New DEStiny Revealed
Aubert, G., Ajroud-Driss, S., Knight, B. P., Shah, S. J. & McNally, E. M., Sep 18 2018, In : Circulation. 138, 12, p. 1267-1271 5 p.Research output: Contribution to journal › Article
Accessory Atrioventricular Bundle
Limb-Girdle Muscular Dystrophies
Heart Block
Syncope
Muscular Diseases
Oxidative stress and cardiovascular risk in type 1 diabetes mellitus: Insights from the DCCT/EDIC study
DCCT/EDIC Research Group, May 15 2018, In : Journal of the American Heart Association. 7, 10, e008368.Research output: Contribution to journal › Article
Diabetes Complications
Type 1 Diabetes Mellitus
Epidemiology
Oxidative Stress
Aryldialkylphosphatase
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial
PATH study group & PATH study group, Jan 1 2018, In : The Lancet Neurology. 17, 1, p. 35-46 12 p.Research output: Contribution to journal › Article
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Immunoglobulins
Placebos
Therapeutics
Intravenous Immunoglobulins
International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome
the IGOS Consortium, Jun 1 2017, In : Journal of the Peripheral Nervous System. 22, 2, p. 68-76 9 p.Research output: Contribution to journal › Article
Guillain-Barre Syndrome
Observational Studies
Cohort Studies
Outcome Assessment (Health Care)
Polyradiculoneuropathy